According to John Hopkins Medicine, 50 to 80 percent of U.S. adults have the oral herpes virus and many don’t know it. Most commonly associated with “cold sores” or “fever blister” the herpes virus can cause other, more serious symptoms as well. These include severe flu-like symptoms, swollen lymph nodes and headaches. The National Institutes of Health (NIH) recently awarded Afsar Naqvi, assistant professor at the University of Illinois, Chicago’s College of Dentistry, a five year, $2 million grant to study this wide spread and yet often misdiagnosed disease.Read More
Science Market Update
Tags: UIC, University of Illinois Chicago, biotech vendor show, Bioresearch, Bioresearch funding, UIChgo, Chicago, University of Illinois at Chicago, Illinois, University of Illinois, research news, BioResearch Product Faire, Cannabinoids, laboratory suppliers, laboratory equipment suppliers, virus research, Biologics, NIH funded Research Projects, NIH grants
When obstructive sleep apnea (OSA) was listed as a contributing factor in the death of actress Carrie Fisher, it brought the condition into the spotlight. Until the news, many people considered sleep apnea to be just a bothersome form of snoring. However, with OSA, breathing is actually interrupted for a few seconds or even several minutes. According to the American sleep apnea association, 38,000 people die annually from heart disease directly complicated by sleep apnea. Now researchers at the University of Illinois, Chicago (UIC) believe they have found the first medication that reduces the effects of OSA, and it's based on a molecule found in the cannabis plant.Read More
Tags: UIC, University of Illinois Chicago, biotech vendor show, Bioresearch, Bioresearch funding, UIChgo, Chicago, University of Illinois at Chicago, Illinois, University of Illinois, research news, BioResearch Product Faire, Cannabinoids, cannabis research, clinical trials, laboratory suppliers, laboratory equipment suppliers
(Image courtesy of Wikimedia commons)
The National Institutes of Health (NIH) awarded a four year, $17.7 million grant to the university of Illinois at Chicago’s Center for Clinical and Transitional Science to further translational research.Read More
Tags: UIC, University of Illinois Chicago, Translational Research, Bioresearch Grant, NIH award, biotech vendor show, Chicago, University of Illiniois, University of Illinois at Chicago, University of Illinois, UI Chicago, UIChgo, 2016
The University of Illinois at Chicago received a two-year, $475,000 grant to study a new treatment for type 1 diabetes that might help protect the pancreas. This promising new treatment would involve using two protein molecules to reduce the damage caused by the body’s autoimmune response. The research led by Dr. Bellur S. Prabhaker, Professor of Microbiology and Immunology at UIC, could eventually free many diabetes patients from the rigors of daily insulin injections.Read More
Tags: UIC, University of Illinois Chicago, Diabetes, Diabetes research, biotech vendor show, Dr. Prabhakar, Bioresearch, Bioresearch funding, UIChgo, 2016, Chicago, University of Illinois at Chicago, Illinois, University of Illinois
The University of Illinois at Chicago is currently ranked in the top fifty for research institutions in the nation, with numerous deparments ranking in the top 10. Hundreds of researchers work throughout the university, investigating cutting-edge life science topics. In order to provide state-of-the-art research facilities to these leading life scientists, the College of Dentistry at UIC just renovated laboratory space on the first, fourth and fifth floors of the college.Read More
For many of the 366 million people around the world who have been diagnosed with type 2 diabetes, insulin injections are an unfortunate but often necessary routine. However, the most recent lab reports from the University of Illinois, Chicago show that in many people, the insulin they need is right inside their own cells, just waiting to be released.
At the University of Illinois at Chicago, biochemists have developed an intuitive solution to the age-old problem of macular degeneration, the leading cause of loss of vision for people over the age of fifty. Their new product is a light-sensitive molecule that can restore vision lost from degenerative eye diseases.
A University of Illinois, Chicago discovery may hold the solution to successfully treating recovering stroke victims. After surviving a stroke, these outpatients can go through years of physical therapy in an attempt to regain one of the most important senses we as people have: our sense of balance. Without it, walking and moving become constant challenges, and the fear of falling becomes an everyday struggle. However, Alexander Aruin, a physical therapy professor at UI Chicago, has made a discovery that could change the lives of these stroke survivors for the better.
Construction of an exciting new research facility was recently announced for the University of Illinois at Chicago. According to a UIC news article, Illinois Governor Quinn declared the commencement of the Advanced Chemical Technology Building (ACTB), which will house researchers from chemistry, biology, and physics. The driving idea behind the building is to foster connections between the three broad fields to focus on specific fields like immunology, orthopedics, tumor growth, and nanoscience.